Speaker Name: Dr. Bryan Williams, President, International Society of Hypertension, Chief of Medicine University, University College, London, UK.

Access this Expert session to:

• Recognize the burden of uncontrolled hypertension in India and BP thresholds and targets outlined in contemporary international guidelines.
• Understand the rationale for early combination therapy using RAS inhibitor with a thiazide or CCB for consistent BP control.
• Interpret PATHWAY-1 trial findings demonstrating improved BP control with initial single-pill combination compared with monotherapy.
• Review SHEP, HYVET, and SPRINT trial outcomes showing reduction in HF, stroke, and major CV events with thiazide-based therapy.
• Evaluate diuretic selection and use in CKD and real-world practice including safety considerations and applicability in high salt intake populations.